Works by Shi, Yuankai
Results: 163
Spatial transcriptomics reveals prognostically LYZ<sup>+</sup> fibroblasts and colocalization with FN1<sup>+</sup> macrophages in diffuse large B-cell lymphoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03968-7
- By:
- Publication type:
- Article
Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI.
- Published in:
- Scientific Data, 2024, v. 11, n. 1, p. 1, doi. 10.1038/s41597-024-04169-0
- By:
- Publication type:
- Article
Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00556
- By:
- Publication type:
- Article
DKK1+ tumor cells inhibited the infiltration of CCL19+ fibroblasts and plasma cells contributing to worse immunotherapy response in hepatocellular carcinoma.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 11, p. 1, doi. 10.1038/s41419-024-07195-3
- By:
- Publication type:
- Article
miR-130a regulates macrophage polarization and is associated with non-small cell lung cancer.
- Published in:
- Oncology Reports, 2015, v. 34, n. 6, p. 3088, doi. 10.3892/or.2015.4301
- By:
- Publication type:
- Article
Small cell lung cancer in the young: Characteristics, diagnosis and outcome data.
- Published in:
- Clinical Respiratory Journal, 2019, v. 13, n. 2, p. 98, doi. 10.1111/crj.12986
- By:
- Publication type:
- Article
Anti‐p53 autoantibody in blood as a diagnostic biomarker for colorectal cancer: A meta‐analysis.
- Published in:
- Scandinavian Journal of Immunology, 2020, v. 91, n. 2, p. N.PAG, doi. 10.1111/sji.12829
- By:
- Publication type:
- Article
A new method of ultra‐performance liquid chromatography/tandem mass spectrometry for determination of chlorogenic acid in human plasma and urine.
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2020, v. 34, n. 5, p. N.PAG, doi. 10.1002/rcm.8603
- By:
- Publication type:
- Article
Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 1, p. 211, doi. 10.1007/s00277-023-05491-0
- By:
- Publication type:
- Article
Event-free survival at 24 months is a robust surrogate endpoint for long-term survival in pediatric, adolescent, and adult T cell lymphoblastic lymphoma.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 12, p. 2847, doi. 10.1007/s00277-020-04195-z
- By:
- Publication type:
- Article
Intensity-modulated radiation therapy followed by GDP chemotherapy for newly diagnosed stage I/II extranodal natural killer/T cell lymphoma, nasal type.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Gemcitabine, dexamethasone, and cisplatin (GDP) as salvage chemotherapy for patients with relapsed or refractory peripheral T cell lymphoma-not otherwise specified.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy, safety, and prognostic factors of apatinib plus platinum doublet chemotherapy in advanced non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Therapeutics, 2022, v. 18, n. 5, p. 1425, doi. 10.4103/jcrt.jcrt_1853_21
- By:
- Publication type:
- Article
Clinicopathologic characteristics and outcome of patients with different EGFR mutations.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2019, v. 15, n. 3, p. 166, doi. 10.1111/ajco.13072
- By:
- Publication type:
- Article
Clinical response to apatinib monotherapy in advanced non-small cell lung cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2018, v. 14, n. 3, p. 264, doi. 10.1111/ajco.12834
- By:
- Publication type:
- Article
Efficacy of icotinib in lung squamous-cell cancer: A real-world experience from single institution.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 6, p. 379, doi. 10.1111/ajco.12669
- By:
- Publication type:
- Article
Comparison of CBV, BEAM and BEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation in non-Hodgkin lymphoma: Efficacy and toxicity.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 5, p. e423, doi. 10.1111/ajco.12610
- By:
- Publication type:
- Article
China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version).
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 1, p. 87, doi. 10.1111/ajco.12608
- By:
- Publication type:
- Article
Quality publishing.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01020-y
- By:
- Publication type:
- Article
Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002).
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01033-1
- By:
- Publication type:
- Article
Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020).
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00977-0
- By:
- Publication type:
- Article
Genetic Profiling of Diffuse Large B-Cell Lymphoma: A Comparison Between Double-Expressor Lymphoma and Non-Double-Expressor Lymphoma.
- Published in:
- Molecular Diagnosis & Therapy, 2023, v. 27, n. 1, p. 75, doi. 10.1007/s40291-022-00621-2
- By:
- Publication type:
- Article
Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Single-cell and spatial analyses revealed the co-location of cancer stem cells and SPP1+ macrophage in hypoxic region that determines the poor prognosis in hepatocellular carcinoma.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00564-3
- By:
- Publication type:
- Article
Sintilimab versus docetaxel as second‐line treatment in advanced or metastatic squamous non‐small‐cell lung cancer: an open‐label, randomized controlled phase 3 trial (ORIENT‐3).
- Published in:
- Cancer Communications, 2022, v. 42, n. 12, p. 1314, doi. 10.1002/cac2.12385
- By:
- Publication type:
- Article
Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first‐line treatment for Chinese patients with unresectable, metastatic, or recurrent non‐squamous non–small‐cell lung cancer: A multicenter, randomized, double‐blinded, phase III trial
- Published in:
- Cancer Communications, 2021, v. 41, n. 9, p. 889, doi. 10.1002/cac2.12179
- By:
- Publication type:
- Article
Association of MUC16 Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 8, p. e2013201, doi. 10.1001/jamanetworkopen.2020.13201
- By:
- Publication type:
- Article
Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomas.
- Published in:
- Hematology, 2016, v. 21, n. 9, p. 536, doi. 10.1080/10245332.2016.1152084
- By:
- Publication type:
- Article
Effect of anlotinib as a third‐ or further‐line therapy in advanced non‐small cell lung cancer patients with different histologic types: Subgroup analysis in the ALTER0303 trial.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 8, p. 2621, doi. 10.1002/cam4.2913
- By:
- Publication type:
- Article
A prognostic model for platinum-doublet as second-line chemotherapy in advanced non-small-cell lung cancer patients.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 6, p. 1116, doi. 10.1002/cam4.689
- By:
- Publication type:
- Article
Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 6, p. 893, doi. 10.20892/j.issn.2095-3941.2021.0193
- By:
- Publication type:
- Article
Current management of chemotherapy-induced neutropenia in adults: key points and new challenges.
- Published in:
- Cancer Biology & Medicine, 2020, v. 17, n. 4, p. 896, doi. 10.20892/j.issn.2095-3941.2020.0069
- By:
- Publication type:
- Article
Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment.
- Published in:
- Cancer Biology & Medicine, 2018, v. 15, n. 4, p. 443, doi. 10.20892/j.issn.2095-3941.2018.0158
- By:
- Publication type:
- Article
Apatinib plus icotinib in treating advanced non-small cell lung cancer after icotinib treatment failure: a retrospective study.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 4989, doi. 10.2147/OTT.S142686
- By:
- Publication type:
- Article
Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 2911, doi. 10.2147/OTT.S102472
- By:
- Publication type:
- Article
Characteristics and Management of TP53-Mutated Diffuse Large B-Cell Lymphoma Patients.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 11515, doi. 10.2147/CMAR.S269624
- By:
- Publication type:
- Article
Safety and efficacy of amulirafusp alfa (IMM0306), a fusion protein of CD20 monoclonal antibody with the CD47 binding domain of SIRPα, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a phase 1/2 study.
- Published in:
- Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01646-2
- By:
- Publication type:
- Article
Antibody response to SARS-CoV-2 WT and Omicron BA.4/5 of inactivated COVID-19 vaccine in patients with lung cancer after second and booster immunization.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01443-3
- By:
- Publication type:
- Article
Co‐mutational assessment of circulating tumour DNA (ctDNA) during osimertinib treatment for T790M mutant lung cancer.
- Published in:
- Journal of Cellular & Molecular Medicine, 2019, v. 23, n. 10, p. 6812, doi. 10.1111/jcmm.14565
- By:
- Publication type:
- Article
Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera<sup>®</sup>) in combination with CHOP in patients with previously untreated CD20‐positive diffuse large B‐cell lymphoma: A randomized, single‐blind, phase III clinical trial
- Published in:
- Hematological Oncology, 2022, v. 40, n. 5, p. 930, doi. 10.1002/hon.3054
- By:
- Publication type:
- Article
Safety and activity of WX-0593 (Iruplinalkib) in patients with ALK- or ROS1-rearranged advanced non-small cell lung cancer: a phase 1 dose-escalation and dose-expansion trial.
- Published in:
- Signal Transduction & Targeted Therapy, 2022, p. 1, doi. 10.1038/s41392-021-00841-8
- By:
- Publication type:
- Article
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0439-6
- By:
- Publication type:
- Article
Different clinical characteristics and treatment strategies for patients with localized sinonasal diffuse large B cell lymphoma and extranodal NK/T cell lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-016-0368-9
- By:
- Publication type:
- Article
The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study.
- Published in:
- PLoS ONE, 2015, v. 10, n. 11, p. 1, doi. 10.1371/journal.pone.0142500
- By:
- Publication type:
- Article
Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology – Mainland China Subset Analysis of the PIONEER study.
- Published in:
- PLoS ONE, 2015, v. 10, n. 11, p. 1, doi. 10.1371/journal.pone.0143515
- By:
- Publication type:
- Article
Study of conditioning regimens with or without high-dose radiotherapy before autologous stem cell transplantation for treating aggressive lymphoma.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Thoracic radiation therapy improves the overall survival of patients with extensive-stage small cell lung cancer with distant metastasis.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 23, p. 5423, doi. 10.1002/cncr.26206
- By:
- Publication type:
- Article
The clinical features, treatment, and prognostic factors for peripheral T‐cell lymphomas: A single‐institution analysis of 240 Chinese patients.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2023, v. 19, n. 5, p. e202, doi. 10.1111/ajco.13831
- By:
- Publication type:
- Article
A new prognostic model including platelet/lymphocyte ratio and International Prognostic Score 3 for freedom from progression in patients with previously untreated advanced classical Hodgkin lymphoma.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 5, p. e486, doi. 10.1111/ajco.13770
- By:
- Publication type:
- Article